Corporate Governance

Board of Directors

Pursuant to Aiforia’s Articles of Association, the company’s Board of Directors comprises from four to seven members and the term of office of Board members ends at the close of the Annual General Meeting following their election. The Board of Directors constitutes a quorum when more than half of its elected members are present. Members with a conflict of interest are excluded when determining the quorum.

Duties of the Board of Directors

In addition to the duties defined in laws and regulations and Aiforia’s Articles of Association, the duties of Aiforia’s Board of Directors include the following:

  • to guide and supervise Aiforia's management and operations;

  • to decide on significant matters pertaining to Aiforia's operations;

  • to review and approve Aiforia's half-yearly reports, annual reports and financial statements;

  • to determine and approve Aiforia's strategy, operating plan and certain policies and practices of Aiforia, as well as to monitor their implementation;

  • to decide on significant business acquisitions, investments and divestments; and

  • to define Aiforia's dividend policy.

Aiforia's Board of Directors convenes according to a schedule agreed in advance and as needed.

The Board of Directors of Aiforia has a Remuneration Committee and an Audit Committee. More information can be found here about these.

Members of the Board of Directors

Pekka Mattila, Chairman of the Board of Directors since 2013

b. 1959
Finnish citizen
Master of Science degree in Technology
Independent of the company and significant shareholders
Company shares: 840,6501
Company options: 3,400 pc, which entitle to subscribed 170,000 shares of the company1

Relevant work experience
  • CEO of Desentum Oy, since 2011

Current positions of trust
  • Chairman of the Board of Directors of Master Golf Course Oy Ab, since 2014
  • Member of the Board of Directors of Oy Medix Biochemica Ab, since 2008
  • Member of the Board of Directors of TILT Biotherapeutics Oy, since 2020
  • Member of the Board of Directors of Musta Aukko Oy, since 2015

Previous positions of trust
  • Chairman of the Board of Directors of Herantis Pharma Oyj
  • Member of the Board of Directors of Mobidiag Oy

--

1) Indirect ownership through Musta Aukko Oy.

Johan Lundin, Member of the Board of Directors since 2013

b. 1964
Finnish citizen
M.D., PhD
Independent of significant shareholders but not independent of the company
Company shares: 1,414,150
Company options: 400 pc, which entitle to subscribed 20,000 shares of the company

Relevant work experience
  • Scientific Advisor at Aiforia, since 2021
  • Research Director and a member of the steering group at the Finnish Institute of Molecular Medicine at the University of Helsinki, since 2011
  • Professor of Medical Technology at Karolinska Institute, since 2019
  • Scientific Director at Aiforia, 2013-2019

Current positions of trust
  • Member of the Committee of Advisors of the European Society of Digital and Integrative Pathology, since 2016

John Sweeney, Member of the Board of Directors since 2021

b. 1970
U.S. citizen
Bachelor of Arts, Economics; MBA
Independent of the company but not independent of significant shareholders
Company shares: 0
Company options: 0

Relevant work experience
  • President and CEO of Epredia, since 2021
  • Senior Vice President & General Manager of Pall Corporation, 2018-2021
  • Senior Vice President & General Manager of Beckman Coulter, 2016-2017

Maria Fe Paz de Paz, Member of the Board of Directors since 2022

b. 1978
Spanish citizen
M.D., PhD MBA
Independent of the company and significant shareholders
Company shares: 0
Company options: 0

Relevant work experience
  • Founder and General Partner of Article25 Capital, since 2019
  • Founder and President of Inflection Point Biomedical Advisors, since 2015
  • Chief Medical Officer at Rosetta Genomics, 2015-2016
  • Chief Medical officer and Founder of Diaceutics, 2009-2016
  • President and Founder of Labceutics, 2009-2015

 

Current positions of trust

  • Founder and Chairwoman of Connect by Circular Lab, since 2020
  • External Advisor at the European Commission, since 2015

 

Previous positions of trust

  • Member of the Board of Directors of Diaceutics, 2009-2016

Jerry Jian Hong, Member of the Board of Directors since 2022

b. 1975
Chinese citizen
MBA
Independent of the company but not independent of significant shareholders
Company shares: 0
Company options: 0

Relevant work experience

  • CEO Ascend Capital, Managing Director Ascend Tapio/Artemis S.a.r.L, since 2020
  • Vice president of SAIC Europe and Managing Director of SAIC Mobility Europe, 2018-2020
  • Assistant President and Executive director, Business Development, SAIC Europe, Managing Director, SAIC Mobility Europe, 2013-2018